Preface

Cancer Metastasis Rev. 2017 Dec;36(4):559-560. doi: 10.1007/s10555-017-9706-9.

Author

Q Ping Dou^{1

2}

Affiliations

¹ Barbara Ann Karmanos Cancer Institute, Departments of Oncology, Pharmacology and Pathology, School of Medicine, Wayne State University, Detroit, MI, 48201-2013, USA. doup@karmanos.org.
² Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, and Affiliated Cancer Hospital & Institute, Guangzhou Medical University, Guangzhou, MI, 511436, People's Republic of China. doup@karmanos.org.

PMID: 29039080
DOI: 10.1007/s10555-017-9706-9

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Cell Transformation, Neoplastic / genetics
Cell Transformation, Neoplastic / metabolism
Disease Progression
Humans
Molecular Targeted Therapy
Neoplasms / drug therapy
Neoplasms / genetics
Neoplasms / metabolism*
Neoplasms / pathology
Proteasome Endopeptidase Complex / metabolism*
Proteasome Inhibitors / pharmacology
Proteasome Inhibitors / therapeutic use

Substances

Proteasome Inhibitors
Proteasome Endopeptidase Complex